Skip Nav Destination
Use of the complement inhibitor Coversin to treat HSCT-associated TMA
Issue Archive
Table of Contents
EXCEPTIONAL CASE REPORTS
Use of the complement inhibitor Coversin to treat HSCT-associated TMA
Clinical Trials & Observations
Timothy H. J. Goodship,Fernando Pinto,Wynn H. Weston-Davies,Juliana Silva,Jun-ichi Nishimura,Miles A. Nunn,Ian Mackie,Samuel J. Machin,Liina Palm,Jeremy W. Pryce,Robert Chiesa,Persis Amrolia,Paul Veys
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
Whole-exome sequencing in evaluation of patients with venous thromboembolism
Eun-Ju Lee,Daniel J. Dykas,Andrew D. Leavitt,Rodney M. Camire,Eduard Ebberink,Pablo García de Frutos,Kavitha Gnanasambandan,Sean X. Gu,James A. Huntington,Steven R. Lentz,Koen Mertens,Christopher R. Parish,Alireza R. Rezaie,Peter P. Sayeski,Caroline Cromwell,Noffar Bar,Stephanie Halene,Natalia Neparidze,Terri L. Parker,Adrienne J. Burns,Anne Dumont,Xiaopan Yao,Cassius Iyad Ochoa Chaar,Jean M. Connors,Allen E. Bale,Alfred Ian Lee
TRANSPLANTATION
VASCULAR BIOLOGY
COMMENTARY
RESPONSE
High-throughput sequencing reveals novel features of immunoglobulin gene rearrangements in Burkitt lymphoma
Katharine A. Lombardo,David G. Coffey,Alicia J. Morales,Christopher S. Carlson,Andrea M. H. Towlerton,Sarah E. Gerdts,Francis K. Nkrumah,Janet Neequaye,Robert J. Biggar,Jackson Orem,Corey Casper,Sam M. Mbulaiteye,Kishor G. Bhatia,Edus H. Warren
-
Cover Image
Cover Image
COVER FIGURE
The JH1 domain of the JAK2 protein. The catalytic loop is highlighted in cyan, the αC loop in yellow, and phosphotyrosines within the activation loop in green. See the article by Lee et al. - PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals